Myeloma News and Research

RSS
Scientists Discover New Class of Molecular Glue Degraders for Cancer Therapy

Scientists Discover New Class of Molecular Glue Degraders for Cancer Therapy

New Insights Into Tumor-Immune Interactions Could Lead to More Effective Therapies for Multiple Myeloma

New Insights Into Tumor-Immune Interactions Could Lead to More Effective Therapies for Multiple Myeloma

Thermo Fisher Scientific Announces the Launch of the EXENT® Solution with IVDR Certification

Thermo Fisher Scientific Announces the Launch of the EXENT® Solution with IVDR Certification

Scientists Uncover New Mechanism for Degrading Short-Lived Proteins

Scientists Uncover New Mechanism for Degrading Short-Lived Proteins

High-Throughput Screening of Existing Drugs to Fight Multiple Myeloma More Effectively

High-Throughput Screening of Existing Drugs to Fight Multiple Myeloma More Effectively

Understanding the relationship between gut microbiome and CAR T-cell therapy response

Understanding the relationship between gut microbiome and CAR T-cell therapy response

Whole genome sequencing might help better assess tumor evolution

Whole genome sequencing might help better assess tumor evolution

Reversal of ADAR1 hyper-editing with small molecule inhibitor

Reversal of ADAR1 hyper-editing with small molecule inhibitor

Cedars-Sinai's Stem Cell and Bone Marrow Transplant Program recognized with two hallmarks of quality

Cedars-Sinai's Stem Cell and Bone Marrow Transplant Program recognized with two hallmarks of quality

Researchers find immune-effective ways to destroy cancer cells

Researchers find immune-effective ways to destroy cancer cells

Researchers discover a new interferon-gamma receptor signaling pathway

Researchers discover a new interferon-gamma receptor signaling pathway

Study shows new potential target for CAR T cells to inhibit solid tumors

Study shows new potential target for CAR T cells to inhibit solid tumors

Yale researchers find a way to 'supercharge' tumor-attacking T cells

Yale researchers find a way to 'supercharge' tumor-attacking T cells

Leukemia-on-a-chip; The Future of Preventing Therapy Resistance?

Leukemia-on-a-chip; The Future of Preventing Therapy Resistance?

High-risk lymphoma patients may receive durable benefit from axi-cel CAR T cell therapy

High-risk lymphoma patients may receive durable benefit from axi-cel CAR T cell therapy

bit.bio appoints Kathryn Corzo as Chief Operating Officer

bit.bio appoints Kathryn Corzo as Chief Operating Officer

Mayo Clinic researchers examine potential new CAR-T cell treatment for multiple myeloma

Mayo Clinic researchers examine potential new CAR-T cell treatment for multiple myeloma

Study identifies new epigenetic control pathways in multiple myeloma growth

Study identifies new epigenetic control pathways in multiple myeloma growth

Low representation of minority groups in genomic databases may impact therapy selection

Low representation of minority groups in genomic databases may impact therapy selection

Genome architectural changes linked to B cell-related blood cancers

Genome architectural changes linked to B cell-related blood cancers

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.